SGLT2-inhibition and myocardial infarction size in patients with type 2 diabetes mellitus- Insights from an acute cardiovascular care center.

The overall three-year incidence of death was 25.8% and SGLT2-I therapy was associated with a significantly lower mortality (Log-rank test: p = 0.035), which however did not reach statistical significance after using the augmented inverse probability weighting approach ( p = 0.63) (Figure 3 ).

also in 111,027 other papers